Search results
Results from the WOW.Com Content Network
The Federal Agency for Medicines and Health Products (FAMHP) of Belgium is responsible for the approval and registration of new medication in Belgium and for pharmacovigilance. Hugues Malonne is the current CEO of the agency.
In the European Union, the Qualified Person Responsible For Pharmacovigilance (QPPV) is an individual, usually an employee of a pharmaceutical company, who is personally responsible for the safety of the human pharmaceutical products marketed by that company in the EU. This function was established in 2004 by article 23 of regulation (EC) No ...
The Kingdom of Belgium has 410 overseas diplomatic missions across all continents with 261 of those being honorary consulates. [1] The honorary consulates of Belgium aid in the issuance of passports and other identification.
Karachi: 1990 Luxury fashion P A Amreli Steels: Basic materials Iron & steel Karachi: 1972 Steel P A Arif Habib Corporation: Conglomerates - Karachi: 1970 [13] Cement, energy, fertilizer, financials, power generation, real estate, steel P A ARY Digital Network: Consumer services Media Karachi: 2000 Media, television, subsidiary of ARY Group ...
National Industrial Parks Development & Management Company (NIP) was created in 2006. [4]NIP is a public-private partnership established to develop focused industrial growth in Pakistan by developing world-class industrial parks all over the country. [5]
In 1965, Y. M. Khan became the first Pakistani chairman of ICI Pakistan at the age of 38. [3] During Khan's leadership, ICI Pakistan focused on industrial expansion, establishing a textile auxiliaries plant in Karachi, a pharmaceutical factory in Narayanganj in East Pakistan, and acquired the Fuller Paints factory in Lahore which was later renamed as Paintex.
This page was last edited on 21 September 2024, at 07:06 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
In 2016, German Merck KGaA executed a binding contract to divest its shareholding in Pakistan to Martin Dow Ltd. [11] [12] [13] In 2016, in a €1.5 million deal, Martin Dow acquired the Laboratoires Salem (before 2010 Bristol-Myers Squibb ) pharmaceutical manufacturing facility in Meymac , France.